Shilei Tang

1.1k total citations · 1 hit paper
15 papers, 810 citations indexed

About

Shilei Tang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shilei Tang has authored 15 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Shilei Tang's work include Extracellular vesicles in disease (4 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (4 papers). Shilei Tang is often cited by papers focused on Extracellular vesicles in disease (4 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (4 papers). Shilei Tang collaborates with scholars based in China. Shilei Tang's co-authors include Shuai He, Xueqiang Peng, Mingyao Huang, Hongyuan Jin, Shuo Yang, Shibo Wei, Jingang Liu, Hangyu Li, Bo Wu and Liang Yang and has published in prestigious journals such as Molecular Cancer, Cancer Letters and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.

In The Last Decade

Shilei Tang

15 papers receiving 801 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications

2022 144 citations Guangpeng He, Xueqiang Peng et al. Molecular Cancer profile →

Peers

Shilei Tang

MB

CR

PRM

IMMUN

ONCOL

Binlu Huang China

Chloe Shay United States

Xiao‐Shun He China

Haibo Han China

Shamir Cassim France

Hechun Lin China

Liang Yu China

Rodrigo Leite de Oliveira Netherlands

Luyun He China

Houjie Liang China

Binlu Huang China

Shilei Tang

590 ×1.0

MB

403 ×1.1

CR

116 ×0.8

PRM

109 ×1.0

IMMUN

133 ×1.3

ONCOL

Citations per year, relative to Shilei Tang Shilei Tang (= 1×) peers Binlu Huang

Countries citing papers authored by Shilei Tang

Since Specialization

Citations

This map shows the geographic impact of Shilei Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilei Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilei Tang more than expected).

Fields of papers citing papers by Shilei Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilei Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilei Tang. The network helps show where Shilei Tang may publish in the future.

Co-authorship network of co-authors of Shilei Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Shilei Tang. A scholar is included among the top collaborators of Shilei Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilei Tang. Shilei Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

He, Guangpeng, Xueqiang Peng, Shibo Wei, et al.. (2022). Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications. Molecular Cancer. 21(1). 19–19. 144 indexed citations breakdown →

2.

Li, Bowen, Shibo Wei, Liang Yang, et al.. (2021). CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 657723–657723. 50 indexed citations

3.

Jin, Hongyuan, Liang Yang, Xueqiang Peng, et al.. (2021). Rab GTPases: Central Coordinators of Membrane Trafficking in Cancer. Frontiers in Cell and Developmental Biology. 9. 648384–648384. 69 indexed citations

4.

Li, Hongwu & Shilei Tang. (2021). Colony Stimulating Factor-1 and its Receptor in Gastrointestinal Malignant Tumors. Journal of Cancer. 12(23). 7111–7119. 9 indexed citations

5.

Peng, Xueqiang, Xinyu Li, Shuo Yang, et al.. (2021). LINC00511 drives invasive behavior in hepatocellular carcinoma by regulating exosome secretion and invadopodia formation. Journal of Experimental & Clinical Cancer Research. 40(1). 183–183. 40 indexed citations

6.

He, Shuai & Shilei Tang. (2020). WNT/β-catenin signaling in the development of liver cancers. Biomedicine & Pharmacotherapy. 132. 110851–110851. 248 indexed citations

7.

Li, Bowen, Liang Yang, Xueqiang Peng, et al.. (2020). Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers. Biomedicine & Pharmacotherapy. 130. 110710–110710. 77 indexed citations

8.

Huang, Mingyao, Xueqiang Peng, Liang Yang, et al.. (2020). Non-coding RNA derived from extracellular vesicles in cancer immune escape: Biological functions and potential clinical applications. Cancer Letters. 501. 234–246. 28 indexed citations

9.

Peng, Xueqiang, Liang Yang, Yingbo Ma, et al.. (2020). IKKβ activation promotes amphisome formation and extracellular vesicle secretion in tumor cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868(1). 118857–118857. 25 indexed citations

10.

Tang, Shilei, et al.. (2019). Scutellarin inhibits the metastasis and cisplatin resistance in glioma cells. OncoTargets and Therapy. Volume 12. 587–598. 15 indexed citations

11.

Tang, Shilei, et al.. (2018). Knockdown of TRIM37 suppresses the proliferation, migration and invasion of glioma cells through the inactivation of PI3K/Akt signaling pathway. Biomedicine & Pharmacotherapy. 99. 59–64. 43 indexed citations

12.

Tang, Shilei, et al.. (2017). PAQR3 inhibits the proliferation, migration and invasion in human glioma cells. Biomedicine & Pharmacotherapy. 92. 24–32. 13 indexed citations

13.

Li, Shijie, Honglin Liu, Shilei Tang, Xiaojuan Li, & Xiao-Yin Wang. (2017). MicroRNA-150 regulates glycolysis by targeting von Hippel-Lindau in glioma cells.. PubMed. 9(3). 1058–1066. 17 indexed citations

14.

Tang, Shilei, et al.. (2015). Wnt/β-catenin up-regulates Midkine expression in glioma cells.. PubMed. 8(8). 12644–9. 9 indexed citations

15.

Tang, Shilei, et al.. (2015). MicroRNA-214 targets PCBP2 to suppress the proliferation and growth of glioma cells.. PubMed. 8(10). 12571–6. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact